Rock Creek Pharmaceuticals Inc. (fka RCPIQ)

[knuts4oe]

Sadly, all three of the major pre-clinical studies ended up the same.

Reviewers found "results interesting" and "should be followed up with further studies", but none were ever done. Without those human studies there is no scientifically acceptable proof that anatabine (and isomyosmine) would be of any benefit to human medical conditions.

The financial value of any asset is whatever you can get someone to pay for it, and obviously no one was willing to offer $250,000.

I have always thought that Jonnie had a plan. Perhaps we will eventually see what that was!